The global custom antibody market is expected to exhibit a 9.6% CAGR between 2018 and 2023, according to a new market intelligence report from Market Research Future (MRFR). The global custom antibody market is primarily driven by the growing demand from the life sciences sector, which has been driven by the growing demand for cellular research. The report presents a comprehensive view of the global custom antibody market to the readers with the help of historical statistics illustrating the growth of the market through the review period along with the market’s current figures, to present reliable forecasts about the market’s movement over the forecast period from 2018 to 2023.Custom antibodies are used in cellular research of all kinds, making them among the most popular products in the biotechnology industry today. Cellular research has taken on a vital role in the investigation into the origin and treatment of diseases such as cardiovascular diseases, infectious diseases, and cancer. This has driven the demand from the global custom antibody market and is likely to remain the major Custom Antibody Market demand driver over the forecast period. The growing incidence of pathogenic and contagious diseases in the world is likely to be a major driver for the market over the forecast period. The increasing role of genetics in cancer research is also likely to be a major driver for the global custom antibody market, as cancer research is likely to be one of the best funded arms of healthcare research over the forecast period.
Companies in the global custom antibody market have gone to great lengths to provide absolute customization, along with online support for data storage and project tracking, which has steadily driven the demand from the market. Genetic research has become more important than ever in the life sciences sector due to its effectiveness in treating diseases at the root cause. This is likely to be one of the major drivers for the global custom antibody market over the forecast period.
Regional Analysis:
The global custom antibody market is likely to be dominated by the Americas and Europe segments over the forecast period due to the presence of a solid, well-equipped research arm for the healthcare sector in these regions. Global pharmaceutical industry leaders are situated mostly in the U.S. or Europe, leading to the two regions accruing a dominant share in the market. The growing healthcare expenditure in the U.S., the UK, Germany, and France is also likely to be a major driver for the custom antibody market over the forecast period. Both Americas and Europe account for more than a third of the global custom antibody market and are likely to retain their dominance over the forecast period due to the growing prospects of the medical research sector in the region and the growing private funding for the healthcare sector.
Competitive Analysis:
Leading players in the global custom antibody market include Thermo Fisher Scientific Inc., Abcam PLC, Bio-Rad Laboratories, Agilent Technology Inc., Rockland Immunochemicals Inc., Proteogenix, Innovagen AB, Promab Biotechnologies Inc., Biolegend Inc., Cell Signaling Technology Inc., Merck Group, and Genscript.
In January 2019, Abcam announced an expansion of their custom antibody catalog with the acquisition of Calico Biolabs.
Read More @ [FURL=https://www.marketresearchfuture.com/reports/custom-antibody-market-7062/]Click Here[/FURL]